Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Neurochem Res ; 41(4): 892-904, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26577396

ABSTRACT

Post-traumatic stress disorder (PTSD) is a psychiatric condition resulting from exposure to a traumatic event. It is characterized by several debilitating symptoms including re-experiencing the past trauma, avoidance behavior, increased fear, and hyperarousal. Key roles in the neuropathology of PTSD and its symptomatology have been attributed to the hippocampus and amygdala. These regions are involved in explicit memory processes and context encoding during fear conditioning. The aim of our study was to investigate whether PTSD is capable of altering the morphology, density and expression of glial fibrillary acidic protein (GFAP) in astrocytes from the CA1 region of the hippocampus and the medial amygdala and correlate the data obtained with the orientation index of the polarity of astrocytes. Thirty male rats were divided in two groups: control (n = 15) and PTSD (n = 15). The inescapable shock protocol, in which the animals are exposed to a single episode of footshock, was used to induce PTSD. Our results show that, in the hippocampus, PTSD is capable of decreasing the density of GFAP+ astrocytes as well as altering astrocytic morphology, as shown by the reductions observed in the total number of primary processes, in the number of primary processes in the lateral quadrants, and the degree of branching in the lateral quadrants. The analysis of the orientation index indicates that PTSD alters the polarity of hippocampal astrocytes. No alterations were observed in the amygdala astrocytes. Therefore, this study demonstrates notable changes in hippocampal astrocytes, supporting the concept that these cells play an important role in PTSD symptomatology.


Subject(s)
Astrocytes/pathology , Astrocytes/physiology , CA1 Region, Hippocampal/pathology , Stress Disorders, Post-Traumatic/pathology , Animals , Cell Count , Cell Polarity , Corticomedial Nuclear Complex/metabolism , Corticomedial Nuclear Complex/pathology , Glial Fibrillary Acidic Protein/metabolism , Male , Rats, Wistar , Stress Disorders, Post-Traumatic/metabolism
2.
Invert Neurosci ; 11(1): 43-51, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21523449

ABSTRACT

Studies have suggested that neuronal loss in Parkinson's disease (PD) could be related to the pacemaker activity of the substantia nigra pars compacta generated by L-type Ca(v) 1.3 calcium channels, which progressively substitute voltage-dependent sodium channels in this region during aging. Besides this mechanism, which leads to increases in intracellular calcium, other factors are also known to play a role in dopaminergic cell death due to overproduction of reactive oxygen species. Thus, dihydropyridines, a class of calcium channel blockers, and resveratrol, a polyphenol that presents antioxidant properties, may represent therapeutic alternatives for the prevention of PD. In the present study, we tested the effects of the dihydropyridines, isradipine, nifedipine, and nimodipine and of resveratrol upon locomotor behavior in Drosophila melanogaster. As previously described, paraquat induced parkinsonian-like motor deficits. Moreover, none of the drugs tested were able to prevent the motor deficits produced by paraquat. Additionally, isradipine, nifedipine, resveratrol, and ethanol (vehicle), when used in isolation, induced motor deficits in flies. This study is the first demonstration that dyhidropyridines and resveratrol are unable to reverse the locomotor impairments induced by paraquat in Drosophila melanogaster.


Subject(s)
Antioxidants , Calcium Channel Blockers/administration & dosage , Dihydropyridines , Nerve Degeneration/chemically induced , Stilbenes , Animals , Antioxidants/administration & dosage , Antioxidants/metabolism , Antioxidants/therapeutic use , Calcium Channel Blockers/metabolism , Calcium Channel Blockers/therapeutic use , Calcium Channels/drug effects , Calcium Channels/metabolism , Dihydropyridines/administration & dosage , Dihydropyridines/metabolism , Dihydropyridines/therapeutic use , Disease Models, Animal , Dopamine/metabolism , Drosophila melanogaster/metabolism , Nerve Degeneration/metabolism , Paraquat , Parkinsonian Disorders/chemically induced , Parkinsonian Disorders/metabolism , Resveratrol , Stilbenes/administration & dosage , Stilbenes/metabolism , Stilbenes/therapeutic use , Substantia Nigra/cytology , Substantia Nigra/drug effects , Substantia Nigra/metabolism
3.
Anat Rec (Hoboken) ; 292(3): 431-8, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19248171

ABSTRACT

Degenerative changes in the temporomandibular joint (TMJ) associated with aging can affect mandibular shape and reduce growth potential when stimulated by functional appliance therapy. This study was designed to evaluate the morphological changes in the mandibles of male mice associated with aging and biomechanical stimulus. Every 3 days over the course of 1 month, the lower incisors were trimmed by 1 mm to induce mandibular advancement (MA) when the animal was feeding. The left mandibles of the 23 experimental and 27 control animals were subsequently dissected, and digital images were obtained to analyze nine linear/angular measurements. Because mandibular morphology depends on the maintenance of condylar cartilage, the surfaces of the condylar cartilage and the ascending ramus of the mandible were also analyzed by scanning electron microscopy (SEM). The linear measurements of the mandible showed changes according to age in the control group and a growth response in the mandibular condyle in 7- and 15-month-old mice after MA. Moreover, SEM analysis revealed depressions in the anterior region of the condylar cartilage and inclined vascular grooves in the ascending ramus in the 7- and 15-month-old experimental mice. Although the growth potential is reduced in mice after 6 months of age, the results showed that continuous growth of the mandible occurs after maturation, except in the condyle, and that biomechanical stimulus of the TMJ of male mice leads to condylar growth. These results suggest that mature and old individuals can favorably respond to maxillary functional orthopedic therapy.


Subject(s)
Aging/physiology , Mandible/anatomy & histology , Mandibular Advancement/methods , Temporomandibular Joint/anatomy & histology , Animals , Body Weight , Male , Mandible/growth & development , Mandible/ultrastructure , Mandibular Condyle/ultrastructure , Mice , Microscopy, Electron, Scanning , Temporomandibular Joint/growth & development , Temporomandibular Joint/ultrastructure
4.
Brain Res ; 1048(1-2): 170-6, 2005 Jun 28.
Article in English | MEDLINE | ID: mdl-15913572

ABSTRACT

The Joro spider toxin (JSTX-3), derived from Nephila clavata, has been found to block glutamate excitatory activity. Epilepsy has been studied in vitro, mostly on rat hippocampus, through brain slices techniques. The aim of this study is to verify the effect of the JSTX-3 on the epileptiform activity induced by magnesium-free medium in rat CA1 hippocampal neurons. Experiments were performed on hippocampus slices of control and pilocarpine-treated Wistar rats, prepared and maintained in vitro. Epileptiform activity was induced through omission of magnesium from the artificial cerebrospinal fluid (0-Mg2+ ACSF) superfusate and iontophoretic application of N-methyl-D-aspartate (NMDA). Intracellular recordings were obtained from CA1 pyramidal neurons both of control and epileptic rats. Passive membrane properties were analyzed before and after perfusion with the 0-Mg2+ ACSF and the application of toxin JSTX-3. During the ictal-like activity, the toxin JSTX-3 was applied by pressure ejection, abolishing this activity. This effect was completely reversed during the washout period when the slices were formerly perfused with artificial cerebrospinal fluid (ACSF) and again with 0-Mg2+ ACSF. Our results suggest that the toxin JSTX-3 is a potent blocker of induced epileptiform activity.


Subject(s)
Anticonvulsants/pharmacology , Heterocyclic Compounds/pharmacology , Hippocampus/cytology , Neurons/drug effects , Polyamines/pharmacology , Action Potentials/drug effects , Animals , Animals, Newborn , Anticonvulsants/therapeutic use , Electric Stimulation , Epilepsy/chemically induced , Epilepsy/drug therapy , Epilepsy/physiopathology , Excitatory Amino Acid Agonists/pharmacology , Heterocyclic Compounds/therapeutic use , In Vitro Techniques , Magnesium/pharmacology , Male , N-Methylaspartate/pharmacology , N-Methylscopolamine , Neurons/physiology , Patch-Clamp Techniques/methods , Polyamines/therapeutic use , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...